RxDoctor Payments Data

Beth McCoy

Nurse Practitioner · Bardstown, KYNPI 1285089375

Payments from drug & device makers

$1,568in general payments, 2019–2025

Across 115 payments — averaging $13.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$689
  • GSK$155
  • Lilly USA, LLC$126
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$88
  • Axsome Therapeutics, Inc.$82
  • Pfizer$69
  • plus $359 from 12 others

What the payments were for

  • Food & beverage$1,568100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,568 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$34,766
Medicare patients
41
Services billed
409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$29,997
OzempicSemaglutide25$28,212
FarxigaDapagliflozin Propanediol31$21,338
QuliptaAtogepant18$19,740
EliquisApixaban37$18,711
LinzessLinaclotide16$12,139
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl103$7,024
XareltoRivaroxaban12$6,635
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen267$6,201
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,775
Carbamazepine ErCarbamazepine32$3,851
JanumetSitagliptin Phos/Metformin Hcl12$3,380
SymbicortBudesonide/Formoterol Fumarate13$2,993
Insulin Lispro Kwikpen U-100Insulin Lispro16$2,544
Albuterol Sulfate HfaAlbuterol Sulfate65$2,330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieQulipta, Linzess$689$31,87934 claims
GSKTrelegy Ellipta$155$29,99733 claims
Novo NordiskOzempic$53$28,21225 claims
AstraZenecaFarxiga, Symbicort$53$24,33144 claims
PfizerEliquis$69$18,71137 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Bardstown

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →